| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 29.292 | 46.213 | 59.152 | 60.378 | 73.627 | 81.587 | 80.816 |
| Total Income - EUR | - | - | - | 29.292 | 46.262 | 59.178 | 60.416 | 73.642 | 81.607 | 80.898 |
| Total Expenses - EUR | - | - | - | 14.168 | 22.321 | 18.399 | 17.494 | 19.634 | 27.361 | 45.352 |
| Gross Profit/Loss - EUR | - | - | - | 15.124 | 23.941 | 40.779 | 42.922 | 54.008 | 54.247 | 35.546 |
| Net Profit/Loss - EUR | - | - | - | 14.833 | 23.477 | 40.228 | 42.317 | 53.270 | 53.429 | 33.120 |
| Employees | - | - | - | 4 | 2 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Ropsimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 1.728 | 2.696 | 1.513 | 780 |
| Current Assets | - | - | - | 18.852 | 24.233 | 44.286 | 44.547 | 57.171 | 60.708 | 39.641 |
| Inventories | - | - | - | 673 | 2.064 | 4.069 | 0 | 953 | 950 | 0 |
| Receivables | - | - | - | 3.717 | 3.838 | 14.409 | 6.848 | 6.788 | 29.732 | 14.072 |
| Cash | - | - | - | 14.463 | 18.330 | 25.808 | 37.699 | 49.430 | 30.026 | 25.569 |
| Shareholders Funds | - | - | - | 14.876 | 23.519 | 40.269 | 43.060 | 54.014 | 54.172 | 33.168 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 3.976 | 714 | 4.017 | 3.215 | 5.852 | 8.049 | 7.252 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ropsimed S.r.l.